The DOI matches its Crossref record; 405 of the 405 references it cites were found in a registry or an index.
Inflammation in sickle cell disease
Open accessAbstract
The primary β-globin gene mutation that causes sickle cell disease (SCD) has significant pathophysiological consequences that result in hemolytic events and the induction of the inflammatory processes that ultimately lead to vaso-occlusion. In addition to their role in the initiation of the acute painful vaso-occlusive episodes that are characteristic of SCD, inflammatory processes are also key components of many of the complications of the disease including autosplenectomy, acute chest syndrome, pulmonary hypertension, leg ulcers, nephropathy and stroke. We, herein, discuss the events that trigger inflammation in the disease, as well as the mechanisms, inflammatory molecules and cells that propagate these inflammatory processes. Given the central role that inflammation plays in SCD pathophysiology, many of the therapeutic approaches currently under pre-clinical and clinical development for the treatment of SCD endeavor to counter aspects or specific molecules of these inflammatory processes and it is possible that, in the future, we will see anti-inflammatory drugs being used either together with, or in place of, hydroxyurea in those SCD patients for whom hematopoietic stem cell transplants and evolving gene therapies are not a viable option.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 405
Systemic Exposure to Morphine and the Risk of Acute Chest Syndrome in Sickle Cell Disease
Kopecky, E. A., Jacobson, S., Joshi, P., & Koren, G. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.10.007 · Cited by 95
Awojoodu, A. O., Keegan, P. M., Lane, A. R., Zhang, Y., Lynch, K. R., Platt, M. O., & Botchwey, E. A. (2014) · Blood · doi:10.1182/blood-2014-01-543652 · Cited by 93
Turhan, A., Jenab, P., Bruhns, P., Ravetch, J. V., Coller, B. S., & Frenette, P. S. (2003) · Blood · doi:10.1182/blood-2003-07-2209 · Cited by 93
Belcher, J. D., Young, M. A., Chen, C., Nguyen, J., Burhop, K. E., Tran, P. D., & Vercellotti, G. M. (2013) · Blood · doi:10.1182/blood-2013-02-486282 · Cited by 93
Self-citationAlmeida, C. B., de Souza, L. E. B., Leonardo, F. C., Costa, F. T. M., WERNECK, C. C., Covas, D. T., Costa, F. F., & Conran, N. (2015) · Blood · doi:10.1182/blood-2014-12-616250 · Cited by 93
Self-citationEnhanced thrombin generation in children with sickle cell disease.
Peters, M., Plaat, B. E. C., Cate, H. T., Wolters, H. J., Weening, R. S., & Brandjes, D. P. M. (1994) · PubMed · Cited by 93
Molecular basis of erythrocyte adhesion to endothelial cells in diseases
Wautier, J., & Wautier, M. (2013) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-2012-1572 · Cited by 92
Inflammatory potential of neutrophils detected in sickle cell disease
Lum, A. F. H., Wun, T., Staunton, D. E., & Simon, S. I. (2004) · American Journal of Hematology · doi:10.1002/ajh.20059 · Cited by 90
High levels of placenta growth factor in sickle cell disease promote pulmonary hypertension
Sundaram, N., Tailor, A., Mendelsohn, L. G., Wansapura, J. P., Wang, X., Higashimoto, T., Pauciulo, M. W., Gottliebson, W. M., Kalra, V. K., Nichols, W. C., et al. (2010) · Blood · doi:10.1182/blood-2009-09-244830 · Cited by 89
Haptoglobin Binding Stabilizes Hemoglobin Ferryl Iron and the Globin Radical on Tyrosine β145
Cooper, C. E., Schaer, D. J., Buehler, P. W., Wilson, M. T., Reeder, B. J., Silkstone, G. G. A., Svistunenko, D. A., Bülow, L., & Alayash, A. I. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4547 · Cited by 89
Setty, Y. B. N., & Betal, S. G. (2007) · Blood · doi:10.1182/blood-2007-07-099465 · Cited by 89
Induction of human fetal hemoglobin via the NRF2 antioxidant response signaling pathway
Macari, E. R., & Lowrey, C. H. (2011) · Blood · doi:10.1182/blood-2010-10-314096 · Cited by 87
Bartolucci, P., Chaar, V., Picot, J., Bachir, D., Habibi, A., Fauroux, C., Galactéros, F., Colin, Y., Kim, C. L. V., & Nemer, W. E. (2010) · Blood · doi:10.1182/blood-2009-12-257444 · Cited by 87
Brun, M., Bourdoulous, S., Couraud, P., Élion, J., Krishnamoorthy, R., & Lapouméroulie, C. (2003) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500176 · Cited by 87
Vasculopathy, inflammation, and blood flow in leg ulcers of patients with sickle cell anemia
Minniti, C. P., Delaney, K., Gorbach, A. M., Xu, D., Lee, C. R., Malik, N., Koroulakis, A. I., Antalek, M. D., Maivelett, J., Peters-Lawrence, M. H., et al. (2013) · American Journal of Hematology · doi:10.1002/ajh.23571 · Cited by 86
The Nitric Oxide Producing Reactions of Hydroxyurea
King, S. B. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033368213 · Cited by 86
Nucleosomes and neutrophil activation in sickle cell disease painful crisis
Schimmel, M., Nur, E., Biemond, B. J., van Mierlo, G. J., Solati, S., Brandjes, D. P. M., Otten, H.-M. M. B., Schnog, J. B., Zeerleder, S. S., & on behalf of the Curama Study Group (2013) · Haematologica · doi:10.3324/haematol.2013.088021 · Cited by 85
Sarray, S., Saleh, L. R., Saldanha, F. L., Al‐Habboubi, H. H., Mahdi, N., & Almawi, W. Y. (2015) · Cytokine · doi:10.1016/j.cyto.2014.11.030 · Cited by 85
Red Blood Cell Microparticles: Clinical Relevance
Rubin, O., Canellini, G., Delobel, J., Lion, N., & Tissot, J. (2012) · Transfusion Medicine and Hemotherapy · doi:10.1159/000342228 · Cited by 84
Belcher, J. D., Vineyard, J. V., Bruzzone, C. M., Chen, C., Beckman, J. D., Nguyen, J., Steer, C. J., & Vercellotti, G. M. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0613-6 · Cited by 84
Self-citationModulation of Proinflammatory Cytokines by Nitric Oxide in Murine Acute Lung Injury
Walley, K. R., McDonald, T., HIGASHIMOTO, Y., & Hayashi, S. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.2.9809081 · Cited by 82
Hossain, M., Qadri, S. M., & Liu, L. (2012) · Journal of Inflammation · doi:10.1186/1476-9255-9-28 · Cited by 82
Zinc and antioxidant vitamin deficiency in patients with severe sickle cell anemia
Hasanato, R. M. W. (2006) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2006.17 · Cited by 81
Novelli, E. M., Kato, G. J., Ragni, M. V., Zhang, Y., Hildesheim, M. E., Nouraie, M. S., Barge, S., Meyer, M. P., Hassett, A. C., Gordeuk, V. R., et al. (2011) · American Journal of Hematology · doi:10.1002/ajh.22274 · Cited by 81
Thrombin generation and cell‐dependent hypercoagulability in sickle cell disease
Whelihan, M. F., Lim, M. Y., Mooberry, M. J., Piegore, M., Ilich, A., Wogu, A. F., Cai, J., Monroe, D. M., Ataga, K. I., Mann, K. G., et al. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13416 · Cited by 81
Sickle red cells induce adhesion of lymphocytes and monocytes to endothelium
Zennadi, R., Chien, A. C., Xu, K., Batchvarova, M., & Telen, M. J. (2008) · Blood · doi:10.1182/blood-2008-01-134346 · Cited by 80
Elevated IL‐8 levels during sickle cell crisis
Duits, A. J., Schnog, J. B., Lard, L. R., Saleh, A. W., & Rojer, R. A. (1998) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1998.tb01092.x · Cited by 80
Musa, B. O. P., Onyemelukwe, G. C., Hambolu, J. O., Mamman, A. I., & Isa, A. H. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00145-09 · Cited by 80
Red blood cell-derived microparticles: An overview
Westerman, M. P., & Porter, J. B. (2016) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2016.04.003 · Cited by 80
Membrane phospholipid asymmetry as a factor in erythrocyte‐endothelial cell interactions
Schlegel, R., Prendergast, T. W., & Williamson, P. (1985) · Journal of Cellular Physiology · doi:10.1002/jcp.1041230210 · Cited by 79
Platelet hyperactivity in sickle-cell disease: a consequence of hyposplenism.
Kenny, M. W., George, A. J., & Stuart, J. (1980) · Journal of Clinical Pathology · doi:10.1136/jcp.33.7.622 · Cited by 79
Hoppe, C. C., Kuypers, F. A., Larkin, S. K., Hagar, W., Vichinsky, E. P., & Styles, L. A. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08480.x · Cited by 78
Cooper, C. E., Silaghi-Dumitrescu, R. L., Rukengwa, M., Alayash, A. I., & Buehler, P. W. (2008) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.03.019 · Cited by 77
Haptoglobin Binding Stabilizes Hemoglobin Ferryl Iron and the Globin Radical on Tyrosine β145
Cooper, C. E., Schaer, D. J., Buehler, P. W., Wilson, M. T., Reeder, B. J., Silkstone, G. G. A., Svistunenko, D. A., Bülow, L., & Alayash, A. I. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4547.test · Cited by 77
Bivalacqua, T. J., Musicki, B., Hsu, L. L.-Y., Berkowitz, D. E., Champion, H. C., & Burnett, A. L. “. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068028 · Cited by 74
Kim, S. Y., Mocanu, C. L., McLeod, D. S., Bhutto, I. A., Merges, C. A., Eid, M. P., Tong, P. Y., & Lutty, G. A. (2003) · Experimental Eye Research · doi:10.1016/s0014-4835(03)00174-x · Cited by 74
Setty, Y. B. N., Key, N. S., Rao, A. K., Betal, S. G., Krishnan, S., Dampier, C., & Stuart, M. J. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09065.x · Cited by 73
Activation of Vascular Endothelial Cell Adhesion Molecule Expression by Sickle Blood Cells
Brown, M. D., Wick, T. M., & Eckman, J. R. (2001) · Fetal and Pediatric Pathology · doi:10.1080/15513810109168817 · Cited by 72
Wun, T., Soulières, D., Frelinger, A. L., Krishnamurti, L., Novelli, E. M., Kutlar, A., Ataga, K. I., Knupp, C., McMahon, L. C., Strouse, J. J., et al. (2013) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-6-17 · Cited by 71
Niu, X., Nouraie, M. S., Campbell, A., RANA, S. R., Minniti, C. P., Sable, C., Darbari, D. S., Dham, N., Reading, N. S., Prchal, J. T., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007956 · Cited by 71
Metformin induces FOXO3-dependent fetal hemoglobin production in human primary erythroid cells
Zhang, Y., Paikari, A., Sumazin, P., Summarell, C. C. G., Crosby, J. R., Boerwinkle, E., Weiss, M. J., & Sheehan, V. (2018) · Blood · doi:10.1182/blood-2017-11-814335 · Cited by 71
Heme-induced cell adhesion in the pathogenesis of sickle-cell disease and inflammation
Wagener, F. A. D. T. G., Abraham, N. G., van Kooyk, Y., de Witte, T., & Figdor, C. G. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01609-6 · Cited by 70
Erythroid adhesion molecules in sickle cell disease: Effect of hydroxyurea
Cartron, J., & Élion, J. (2008) · Transfusion Clinique et Biologique · doi:10.1016/j.tracli.2008.05.001 · Cited by 70
Phase 1 Study of the E-Selectin Inhibitor GMI 1070 in Patients with Sickle Cell Anemia
Wun, T., Styles, L., DeCastro, L., Telen, M. J., Kuypers, F., Cheung, A., Kramer, W., Flanner, H., Rhee, S., Magnani, J. L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101301 · Cited by 69
Microparticles in sickle cell anaemia: promise and pitfalls
Hebbel, R. P., & Key, N. S. (2016) · British Journal of Haematology · doi:10.1111/bjh.14112 · Cited by 69
Wood, K. C., Hebbel, R. P., & Granger, D. N. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01056.2003 · Cited by 68
Hemostatic Alterations in Sickle Cell Disease: Relationships to Disease Pathophysiology
Stuart, M. J., & Setty, Y. B. N. (2001) · Fetal and Pediatric Pathology · doi:10.1080/15513810109168816 · Cited by 68
Seki, J., Nishio, M., Kato, Y., Motoyama, Y., & Yoshida, K. (1995) · Atherosclerosis · doi:10.1016/0021-9150(95)05563-c · Cited by 67
Barodka, V. M., Nagababu, E., Mohanty, J. G., Nyhan, D. P., Berkowitz, D. E., Rifkind, J. M., & Strouse, J. J. (2013) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2013.10.004 · Cited by 66
Chen, L., Zhang, X., Chen‐Roetling, J., & Regan, R. F. (2010) · Journal of neurosurgery · doi:10.3171/2010.10.jns10861 · Cited by 66
Ma, B., Day, J., Phillips, H., Slootsky, B., Tolosano, E., & Doré, S. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0490-1 · Cited by 66
Arumugam, P. I., Mullins, E. S., Shanmukhappa, S. K., Monia, B. P., Loberg, A., Shaw, M. A., Rizvi, T. A., Wansapura, J. P., Degen, J. L., & Malik, P. (2015) · Blood · doi:10.1182/blood-2015-01-625707 · Cited by 64
Nonrandom association of free iron with membranes of sickle and beta- thalassemic erythrocytes
Repka, T. L., Shalev, O., Reddy, R. K., Yuan, J., Abrahamov, A., Rachmilewitz, E. A., Low, P. S., & Hebbel, R. (1993) · Blood · doi:10.1182/blood.v82.10.3204.3204 · Cited by 63
Aslan, M., & Freeman, B. A. (2004) · PubMed · Cited by 63
Endothelial Activation by Platelets from Sickle Cell Anemia Patients
Proença‐Ferreira, R., Brugnerotto, A. F., Garrido, V. T., Dominical, V. M., Vital, D. M., Ribeiro, M. D. F. R., Melissa, E. D. S., Traina, F., Saad, S. T. O., Costa, F. F., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089012 · Cited by 62
Self-citationHally, K. E., Flamme, A. C. L., Larsen, P., & Harding, S. A. (2017) · Thrombosis Research · doi:10.1016/j.thromres.2017.07.031 · Cited by 62
Gambero, S., Canalli, A. A., Traina, F., de Albuquerque, D. M., Saad, S. T. O., Costa, F. F., & Conran, N. (2006) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2006.00788.x · Cited by 61
Self-citationFranco, R., Palascak, M. B., Thompson, H., Rucknagel, D., & Joiner, C. (1996) · Blood · doi:10.1182/blood.v88.11.4359.4359 · Cited by 61
Conran, N., Saad, S. T. O., Costa, F. F., & Ikuta, T. (2007) · Annals of Hematology · doi:10.1007/s00277-006-0246-6 · Cited by 60
Self-citationArnold, S. D., Bhatia, M., Horan, J., & Krishnamurti, L. (2016) · British Journal of Haematology · doi:10.1111/bjh.14167 · Cited by 60
Simvastatin reduces vaso‐occlusive pain in sickle cell anaemia: a pilot efficacy trial
Hoppe, C. C., Jacob, E., Styles, L. A., Kuypers, F. A., Larkin, S. K., & Vichinsky, E. P. (2017) · British Journal of Haematology · doi:10.1111/bjh.14580 · Cited by 60
Cellular Adhesion and the Endothelium
Kutlar, A., & Embury, S. H. (2014) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2013.11.007 · Cited by 59
Hydroxyurea is associated with reductions in hypercoagulability markers in sickle cell anemia
Colella, M. P., Paula, E. V. D., Conran, N., Machado‐Neto, J. A., Annicchino-Bizzacchi, J. M., Costa, F. F., Saad, S. T. O., & Traina, F. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04861.x · Cited by 59
Self-citationSickle cell disease increases high mobility group box 1: a novel mechanism of inflammation
Xu, H., Wandersee, N. J., Guo, Y. H., Jones, D. W., Holzhauer, S., Hanson, M. S., Machogu, E. M., Brousseau, D. C., Hogg, N., Densmore, J. C., et al. (2014) · Blood · doi:10.1182/blood-2014-04-560813 · Cited by 59
Circulating cytokines response and the level of erythropoiesis in sickle cell anemia
Croizat, H., & Nagel, R. L. (1999) · American Journal of Hematology · Cited by 59
Chaar, V., Picot, J., Renaud, O., Bartolucci, P., Nzouakou, R., Bachir, D., Galactéros, F., Colin, Y., Kim, C. L. V., & Nemer, W. E. (2010) · Haematologica · doi:10.3324/haematol.2010.026294 · Cited by 59
Kassa, T., Jana, S., Strader, M. B., Meng, F., Jia, Y., Wilson, M. T., & Alayash, A. I. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.651257 · Cited by 57
Does physical activity increase or decrease the risk of sickle cell disease complications?
Martin, C., Pialoux, V., Faës, C., Charrin, E., Skinner, S. C., & Connes, P. (2015) · British Journal of Sports Medicine · doi:10.1136/bjsports-2015-095317 · Cited by 57
Balayssac‐Siransy, E., Connes, P., Tuo, N., Danho, C., Diaw, M., Sanogo, I., Hardy‐Dessources, M., Samb, A., Ballas, S. K., & Bogui, P. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08728.x · Cited by 56
Laboratory and echocardiography markers in sickle cell patients with leg ulcers
Minniti, C. P., Taylor, J. G., Hildesheim, M. E., Oneal, P. A., Wilson, J., Castro, O. L., Gordeuk, V. R., & Kato, G. J. (2011) · American Journal of Hematology · doi:10.1002/ajh.22065 · Cited by 56
Faës, C., Balayssac‐Siransy, E., Connes, P., Hivert, L., Danho, C., Bogui, P., Martin, C., & Pialoux, V. (2013) · British Journal of Haematology · doi:10.1111/bjh.12594 · Cited by 56
Schaer, C. A., Vallelian, F., Imhof, A., Schoedon, G., & Schaer, D. J. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0706453 · Cited by 56
A Phase Ib open label, randomized, safety study of SANGUINATE™ in patients with sickle cell anemia
Misra, H. K., Bainbridge, J., Berryman, J., Abuchowski, A., Galvez, K. M., Uribe, L., Hernandez, A. L., & Sosa, N. R. (2016) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.1016/j.bjhh.2016.08.004 · Cited by 56
Placenta growth factor in sickle cell disease: association with hemolysis and inflammation
Brittain, J. E., Hulkower, B., Jones, S., Strayhorn, D., Castro, L. D., Telen, M. J., Orringer, E. P., Hinderliter, A. L., & Ataga, K. I. (2009) · Blood · doi:10.1182/blood-2009-04-217950 · Cited by 55
The immune response to severe bacterial infections: consequences for therapy
Giamarellos‐Bourboulis, E. J., & Raftogiannis, M. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.2 · Cited by 55
Sickle cell disease: an inherited thrombophilia
Wun, T., & Brunson, A. M. (2016) · Hematology · doi:10.1182/asheducation-2016.1.640 · Cited by 55
Koehl, B., Nivoit, P., Nemer, W. E., Lenoir, O., Hermand, P., Pereira, C., Brousse, V. A. M., Guyonnet, L., Ghinatti, G., Benkerrou, M., et al. (2017) · Haematologica · doi:10.3324/haematol.2016.156869 · Cited by 55
Hemin Causes Lung Microvascular Endothelial Barrier Dysfunction by Necroptotic Cell Death
Singla, S., Sysol, J. R., Dille, B., Jones, N., Chen, J., & Machado, R. F. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0287oc · Cited by 55
A novel inflammatory role for platelets in sickle cell disease
Davila, J. G., Manwani, D. G., Vasović, L. V., Avanzi, M. P., Uehlinger, J., Ireland, K., & Mitchell, W. B. (2014) · Platelets · doi:10.3109/09537104.2014.983891 · Cited by 54
Autoxidation, dehydration, and adhesivity may be related abnormalities of sickle erythrocytes
Hebbel, R. P., Ney, P. A., & Foker, W. (1989) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1989.256.3.c579 · Cited by 54
Gomperts, E. D., Belcher, J. D., Otterbein, L. E., Coates, T. D., Wood, J. C., Skolnick, B. E., Levy, H. A., & Vercellotti, G. M. (2017) · American Journal of Hematology · doi:10.1002/ajh.24750 · Cited by 54
Self-citationEvaluation of Novel Fetal Hemoglobin Inducer Drugs in Treatment of β-Hemoglobinopathy Disorders.
Fard, A. D., Hosseini, S. A., Shahjahani, M., Salari, F., & Jaseb, K. (2013) · PubMed Central · Cited by 53
Minniti, C. P., Gorbach, A. M., Xu, D., Hon, Y. Y., Delaney, K., Seidel, M., Malik, N., Peters-Lawrence, M. H., Cantilena, C., Nichols, J. S., et al. (2014) · The Lancet Haematology · doi:10.1016/s2352-3026(14)00019-2 · Cited by 53
Telen, M. J., Batchvarova, M., Shan, S., Bovée‐Geurts, P. H. M., Zennadi, R., Leitgeb, A. M., Brock, R. E., & Lindgren, M. (2016) · British Journal of Haematology · doi:10.1111/bjh.14303 · Cited by 53
Leite‐de‐Moraes, M., Diem, S., Michel, M., Ohtsu, H., Thurmond, R. L., Schneider, E., & Dy, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1233 · Cited by 52
Bartzeliotou, Α., Margeli, A. P., Tsironi, M., Skenderi, K., Bacoula, C., Chrousos, G. P., & Papassotiriou, I. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2007.01.013 · Cited by 52
Vercellotti, G. M., Zhang, P., Nguyen, J., Abdulla, F. A., Chen, C., Nguyen, P., Nowotny, C., Steer, C. J., Smith, A., & Belcher, J. D. (2016) · Molecular Medicine · doi:10.2119/molmed.2016.00063 · Cited by 52
Self-citationComplement Activation during Painful Crisis in Sickle Cell Anemia
Mold, C., Tamerius, J. D., & Phillips, G. (1995) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1995.1131 · Cited by 51
Inhaled carbon monoxide reduces leukocytosis in a murine model of sickle cell disease
Beckman, J. D., Belcher, J. D., Vineyard, J. V., Chen, C., Nguyen, J., Nwaneri, M. O., O’Sullivan, M. G., Gulbahce, E. H., Hebbel, R. P., & Vercellotti, G. M. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00327.2009 · Cited by 51
Self-citationChintagari, N. R., Jana, S., & Alayash, A. I. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2015-0197oc · Cited by 51
Patients with Sickle Cell Disease have Reduced Blood Antioxidant Protection
Ren, R., Ghebremeskel, K., Okpala, Lee, Ibegbulam, & Crawford (2008) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831.78.3.139 · Cited by 50
dos Santos, J. L., Lanaro, C., Lima, L. M., Gambero, S., Franco‐Penteado, C. F., Alexandre‐Moreira, M. S., Wade, M. F., Yerigenahally, S. D., Kutlar, A., Meiler, S. E. L., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200531f · Cited by 50
Rusanova, I., Escames, G., Cossio, G., Borace, R. G. D., Moreno, B., Chahboune, M., López, L. C., Diez, T. A., & Acuña-Castroviejo, D. (2010) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2010.01528.x · Cited by 50
Chaar, V., Laurance, S., Lapouméroulie, C., Cochet, S., Grandis, M. D., Colin, Y., Élion, J., Kim, C. L. V., & Nemer, W. E. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.506121 · Cited by 50
Krishnamoorthy, S., Pace, B. S., Gupta, D., Sturtevant, S., Li, Y., Makala, L., Brittain, J. E., Moore, N., Vieira, B. F., Thullen, T. D., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.96409 · Cited by 50
Fibronectin bridges monocytes and reticulocytes via integrin α4β1
Brittain, J. E., Knoll, C. M., Ataga, K. I., Orringer, E. P., & Parise, L. V. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07056.x · Cited by 49
Inhibition of endothelium-dependent vasorelaxation by sickle erythrocytes
Mosseri, M., Bartlett-Pandite, A. N., Wenc, K., Isner, J. M., & Weinstein, R. S. (1993) · American Heart Journal · doi:10.1016/0002-8703(93)91049-k · Cited by 49
Elevated hypercoagulability markers in hemoglobin SC disease
Colella, M. P., Paula, E. V. D., Machado‐Neto, J. A., Conran, N., Annichino‐Bizzacchi, J. M., Costa, F. F., Saad, S. T. O., & Traina, F. (2015) · Haematologica · doi:10.3324/haematol.2014.114587 · Cited by 49
Self-citationIntegrin-Mediated Cell-Matrix Interaction in Physiological and Pathological Blood Vessel Formation
Niland, S., & Eble, J. A. (2011) · Journal of Oncology · doi:10.1155/2012/125278 · Cited by 48
Lopes, F. C. M., Traina, F., Almeida, C. B., Leonardo, F. C., Franco‐Penteado, C. F., Garrido, V. T., Colella, M. P., Soares, R. A., Saad, S. T. O., Costa, F. F., et al. (2015) · Haematologica · doi:10.3324/haematol.2014.119727 · Cited by 48
Self-citationRelationship between oxidative stress, ferritin and insulin resistance in sickle cell disease.
Al‐Sultan, A. I., Seif, M. A., Amin, T. T., Mr, A. N., & AlSuliman, A. M. (2010) · PubMed · Cited by 48
Dominical, V. M., Samsel, L., Nichols, J. S., Costa, F. F., McCoy, J. P., Conran, N., & Kato, G. J. (2014) · Haematologica · doi:10.3324/haematol.2014.108555 · Cited by 47
Self-citationAltered heme-mediated modulation of dendritic cell function in sickle cell alloimmunization
Godefroy, E., Liu, Y., Shi, P. A., Mitchell, W. B., Cohen, D., Chou, S. T., Manwani, D. G., & Yazdanbakhsh, K. (2016) · Haematologica · doi:10.3324/haematol.2016.147181 · Cited by 47
Hierso, R., Lemonne, N., Villaescusa, R., Lalanne‐Mistrih, M., Charlot, K., Etienne‐Julan, M., Tressières, B., Lamarre, Y., Tarer, V., Garnier, Y., et al. (2016) · British Journal of Haematology · doi:10.1111/bjh.14476 · Cited by 47
Kinetic assay shows that increasing red cell volume could be a treatment for sickle cell disease
Li, Q., Henry, E. R., Hofrichter, J., Smith, J. F., Cellmer, T., Dunkelberger, E. B., Metaferia, B. B., Jones-Straehle, S., Boutom, S., Christoph, G. W., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1619054114 · Cited by 47
Solovey, A. N., Kollander, R., Milbauer, L. C., Abdulla, F. A., Chen, Y., Kelm, R. J., & Hebbel, R. P. (2009) · American Journal of Hematology · doi:10.1002/ajh.21582 · Cited by 46
Setty, Y. B. N., & Stuart, M. J. (2002) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2002.121200 · Cited by 45
The effect of carbon monoxide on red cell life span in sickle cell disease
Beutler, E. (1975) · Blood · doi:10.1182/blood.v46.2.253.253 · Cited by 44
Canalli, A. A., Franco‐Penteado, C. F., Traina, F., Saad, S. T. O., Costa, F. F., & Conran, N. (2007) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2007.00926.x · Cited by 44
Self-citationCerqueira, B. A. V., Boas, W. V., Zanette, Â., dos Reis, M. G., & Gonçalves, M. D. S. (2011) · Cytokine · doi:10.1016/j.cyto.2011.08.013 · Cited by 44
Patterns of exercise-related inflammatory response in sickle cell trait carriers
Julien Tripette, A., Connes, P., Hédreville, M., Etienne‐Julan, M., Marlin, L., Hüe, O., & Hardy‐Dessources, M. (2008) · British Journal of Sports Medicine · doi:10.1136/bjsm.2008.047530 · Cited by 44
A pilot study of eptifibatide for treatment of acute pain episodes in sickle cell disease
Desai, P. C., Brittain, J. E., Jones, S., McDonald, A., Wilson, D. R., Dominik, R., Key, N. S., Parise, L. V., & Ataga, K. I. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.08.002 · Cited by 43
Differential Expression of E‐ and P‐Selectin in the Microvasculature of Sickle Cell Transgenic Mice
Wood, K., Russell, J., Hebbel, R. P., & Granger, D. N. (2004) · Microcirculation · doi:10.1080/10739680490437559 · Cited by 42
Polynitroxyl albumin inhibits inflammation and vasoocclusion in transgenic sickle mice
Mahaseth, H., Vercellotti, G. M., Welch, T. E., Bowlin, P. R., Sonbol, K. M., Hsia, C. J. C., Ma, L., Bischof, J. C., Hebbel, R. P., & Belcher, J. D. (2005) · Journal of Laboratory and Clinical Medicine · doi:10.1016/j.lab.2005.02.008 · Cited by 42
Self-citationHabitual Physical Activity and Endothelial Activation in Sickle Cell Trait Carriers
Aufradet, É., Monchanin, G., Oyono-Enguéllé, S., Féasson, L., Messonnier, L. A., Francina, A., Bezin, L., Serpero, L. D., Gozal, D., DODOGBA, M., et al. (2010) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181e054d6 · Cited by 42
Sickle cell adhesion depends on hemodynamics and endothelial activation
Wagner, M. C., Eckman, J. R., & Wick, T. M. (2004) · Journal of Laboratory and Clinical Medicine · doi:10.1016/j.lab.2004.08.004 · Cited by 41
In vitro and in vivo anti-angiogenic effects of hydroxyurea
Lopes, F. C. M., Ferreira, R., de Albuquerque, D. M., Silveira, A. A. A., Costa, R., Soares, R. A., Costa, F. F., & Conran, N. (2014) · Microvascular Research · doi:10.1016/j.mvr.2014.05.009 · Cited by 41
Self-citationTargeting NADPH Oxidase Decreases Oxidative Stress in the Transgenic Sickle Cell Mouse Penis
Musicki, B., Liu, T., Sezen, S. F., & Burnett, A. L. “. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02798.x · Cited by 40
Plasma interleukin-1β concentration is associated with stroke in sickle cell disease
Asare, K., Gee, B. E., Stiles, J. K., Wilson, N. O., Driss, A., Quarshie, A., Adams, R. J., Kutlar, A., & Hibbert, J. M. (2009) · Cytokine · doi:10.1016/j.cyto.2009.10.002 · Cited by 40
Canalli, A. A., Proenca, R. F., Franco‐Penteado, C. F., et al. (2010) · Haematologica · doi:10.3324/haematol.2010.032912 · Cited by 40
Vercellotti, G. M., Khan, F. B., Nguyen, J., Chen, C., Bruzzone, C. M., Bechtel, H., Brown, G., Nath, K. A., Steer, C. J., Hebbel, R. P., et al. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00079 · Cited by 39
Self-citationIncreased activation of the alternative complement pathway in sickle cell disease
Chudwin, D. S., Korenblit, A. D., Kingzette, M., Artrip, S. G., & Rao, S. (1985) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(85)90139-4 · Cited by 39
Almeida, C. B., Traina, F., Lanaro, C., Canalli, A. A., Saad, S. T. O., Costa, F. F., & Conran, N. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07264.x · Cited by 39
Self-citationMohan, J. S. (2005) · British Journal of Ophthalmology · doi:10.1136/bjo.2004.058164 · Cited by 39
Erythroid Adhesion Molecules in Sickle Cell Anaemia Infants: Insights Into Early Pathophysiology
Brousse, V. A. M., Colin, Y., Pereira, C., Arnaud, C., Odièvre, M. H., Boutemy, A., Guitton, C., de Montalembert, M., Lapouméroulie, C., Picot, J., et al. (2014) · EBioMedicine · doi:10.1016/j.ebiom.2014.12.006 · Cited by 39
Patel, N. N., Sundaram, N., Yang, M., Madigan, C., Kalra, V. K., & Malik, P. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.101691 · Cited by 38
Decreased plasma endothelin-1 levels in children with sickle cell disease treated with hydroxyurea.
Lapouméroulie, C., Benkerrou, M., Odièvre, M. H., Ducrocq, R., Brun, M., & Élion, J. (2005) · PubMed · Cited by 37
Garrido, V. T., Proença‐Ferreira, R., Dominical, V. M., Traina, F., Bezerra, M., de Mello, M. R. B., Colella, M. P., Araujo, A. S., Saad, S. T. O., Costa, F. F., et al. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09218.x · Cited by 37
Self-citationSakamoto, T. M., Lanaro, C., Ozelo, M. C., Garrido, V. T., Saad, S. T. O., Conran, N., & Costa, F. F. (2013) · Microvascular Research · doi:10.1016/j.mvr.2013.10.002 · Cited by 37
Self-citationAnalysis of Histamine Receptor Knockout Mice in Models of Inflammation
Neumann, D., Schneider, E. H., & Seifert, R. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.204214 · Cited by 37
Sickle cell vaso-occlusive crisis induces the release of circulating serum heat shock protein-70
Adewoye, A. H., Klings, E. S., Farber, H. W., Palaima, E., Bausero, M. A., McMahon, L. C., Odhiambo, A., Safaya, S., Yoder, M. A., Steinberg, M. H., et al. (2005) · American Journal of Hematology · doi:10.1002/ajh.20292 · Cited by 36
Barcelos, R. P., Bresciani, G., Rodriguez‐Miguelez, P., Cuevas, M. J., Soares, F. A. A., Barbosa, N. V., & González‐Gallego, J. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.02.006 · Cited by 36
Field, J. J., Majerus, E. M., Ataga, K. I., Vichinsky, E. P., Schaub, R. G., Mashal, R. D., & Nathan, D. G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171067 · Cited by 35
Lin, G., Field, J. J., Yu, J. C., Ken, R., Neuberg, D. S., Nathan, D. G., & Linden, J. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074664 · Cited by 34
Nonhematopoietic Nrf2 dominantly impedes adult progression of sickle cell anemia in mice
Ghosh, S., Ihunnah, C. A., Hazra, R., Walker, A. L., Hansen, J. M., Archer, D. R., Owusu-Ansah, A. T., & Ofori-Acquah, S. F. (2016) · JCI Insight · doi:10.1172/jci.insight.81090 · Cited by 34
Modulation of redox pathways in neutrophils from sickle cell disease patients
Aslan, M., & Canatan, D. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2008.07.004 · Cited by 33
Potential therapeutic action of nitrite in sickle cell disease
Wajih, N., Basu, S., Jailwala, A., Kim, H. W., Ostrowski, D., Perlegas, A. S., Bolden, C. A., Buechler, N. L., Gladwin, M. T., Caudell, D. L., et al. (2017) · Redox Biology · doi:10.1016/j.redox.2017.05.006 · Cited by 33
Moderate exercise training decreases inflammation in transgenic sickle cell mice
Charrin, E., Dubé, J. J., Connes, P., Pialoux, V., Ghosh, S., Faës, C., Ofori-Acquah, S. F., & Martin, C. (2017) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2017.06.002 · Cited by 33
Therapeutics Targeting of Dysregulated Redox Equilibrium and Endothelial Dysfunction
Risbano, M. G., & Gladwin, M. T. (2013) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-662-45805-1_13 · Cited by 32
Pathophysiologic Role of Histamine: Evidence Clarified by Histidine Decarboxylase Gene Knockout Mice
Ohtsu, H. (2012) · International Archives of Allergy and Immunology · doi:10.1159/000337735 · Cited by 32
Inflammatory and oxidative stress phenotypes in transgenic sickle cell mice
Charrin, E., Ofori-Acquah, S. F., Nader, É., Skinner, S. C., Connes, P., Pialoux, V., Joly, P., & Martin, C. (2016) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2016.10.020 · Cited by 32
Solovey, A. N., Somani, A., Belcher, J. D., Milbauer, L. C., Vincent, L., Pawliński, R., Nath, K. A., Kelm, R. J., Mackman, N., O’Sullivan, M. G., et al. (2017) · American Journal of Hematology · doi:10.1002/ajh.24856 · Cited by 32
Self-citationSilveira, A. A. A., Dominical, V. M., Almeida, C. B., Chweih, H., Ferreira, W. A., Vicente, C. P., Costa, F. T. M., WERNECK, C. C., Costa, F. F., & Conran, N. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a0916-388rr · Cited by 32
Self-citationUgocsai, P., Barlage, S., Dada, A. M., & Schmitz, G. (2006) · Cytometry Part A · doi:10.1002/cyto.a.20235 · Cited by 30
Cheung, A., Chan, M. S., Ramanujam, S., Rangaswami, A. A., Curl, K., Franklin, P., & Wun, T. (2004) · Journal of Investigative Medicine · doi:10.1136/jim-52-06-35 · Cited by 29
Belisário, A. R., Nogueira, F. L., Rodrigues, R. S., de Toledo, N. E., Cattabriga, A. L. M., Velloso‐Rodrigues, C., Duarte, F. O. C., Silva, C. M., & Viana, M. B. (2014) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2014.08.001 · Cited by 29
Platelet activation as a marker for in vivo prothrombotic activity: detection by flow cytometry.
Tomer, A. (2005) · PubMed · Cited by 29
Liem, R. I., Onyejekwe, K., Olszewski, M., Nchekwube, C., Zaldivar, F. P., Radom‐Aizik, S., Rodeghier, M., & Thompson, A. A. (2015) · British Journal of Haematology · doi:10.1111/bjh.13782 · Cited by 28
Vaso-occlusion in Sickle Cell Disease
Kurantsin‐Mills, J., Klug, P., & Lessin, L. S. (1988) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-198824000-00019 · Cited by 28
Neutrophil extracellular traps (Nets) impact upon autoimmune disorders
Pruchniak, M. P., Kotuła, I., & Manda‐Handzlik, A. (2015) · Central European Journal of Immunology · doi:10.5114/ceji.2015.52836 · Cited by 28
Krajewski, M. L., Hsu, L. L.-Y., & Gladwin, M. T. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00499.2008 · Cited by 28
Parrow, N. L., Tu, H., Nichols, J., Violet, P.-C., Pittman, C. A., Fitzhugh, C. D., Fleming, R. E., Mohandas, N., Tisdale, J. F., & Levine, M. (2017) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2017.04.005 · Cited by 28
Histamine increases sickle erythrocyte adherence to endothelium
Wagner, M. C., Eckman, J. R., & Wick, T. M. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05880.x · Cited by 27
The Role of Adenosine Signaling in Sickle Cell Therapeutics
Field, J. J., Nathan, D. G., & Linden, J. M. (2014) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2013.11.003 · Cited by 27
Association of plasma CD40L with acute chest syndrome in sickle cell anemia
Garrido, V. T., Sonzogni, L., Nkya, S. W., Costa, F. F., Conran, N., & Thein, S. L. (2017) · Cytokine · doi:10.1016/j.cyto.2017.05.017 · Cited by 27
Self-citationHanson, M. S., Piknova, B., Keszler, Á., Diers, A. R., Wang, X., Gladwin, M. T., Hillery, C. A., & Hogg, N. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08738.x · Cited by 26
Conran, N., Almeida, C. B., Lanaro, C., Proença‐Ferreira, R., Traina, F., Saad, S. T. O., & Costa, F. F. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06748.x · Cited by 26
Self-citationProença‐Ferreira, R., Franco‐Penteado, C. F., Traina, F., Saad, S. T. O., Costa, F. F., & Conran, N. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08087.x · Cited by 26
Self-citationOverview of Sickle Cell Anemia Pathophysiology
Steinberg, M. H. (2016) · Springer eBooks · doi:10.1007/978-3-319-06713-1_3 · Cited by 26
Nur, E., van Beers, E. J., Martina, S., Cuccovillo, I., Otten, H.-M., Schnog, J. B., Meijers, J. C. M., Mantovani, A., Brandjes, D. P. M., Bottazzi, B., et al. (2011) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2010.10.016 · Cited by 25
Role of Exercise-Induced Oxidative Stress in Sickle Cell Trait and Disease
Chirico, E. N., Faës, C., Connes, P., Canet‐Soulas, E., Martin, C., & Pialoux, V. (2015) · Sports Medicine · doi:10.1007/s40279-015-0447-z · Cited by 24
Kamal, J. K. A., & Behere, D. V. (2005) · PubMed · Cited by 24
Noubouossie, D. F., Lê, P.-Q., Rozen, L., Ziereisen, F., Willems, D., Demulder, A., & Ferster, A. (2013) · European Journal Of Haematology · doi:10.1111/ejh.12113 · Cited by 23
Hydroxycarbamide reduces eosinophil adhesion and degranulation in sickle cell anaemia patients
Pallis, F. R., Conran, N., Fertrin, K. Y., Saad, S. T. O., Costa, F. F., & Franco‐Penteado, C. F. (2013) · British Journal of Haematology · doi:10.1111/bjh.12628 · Cited by 23
Self-citationGenome-wide association study of erythrocyte density in sickle cell disease patients
Ilboudo, Y., Bartolucci, P., Rivera, A., Sedzro, J.-C., Beaudoin, M., Trudel, M., Alper, S. L., Brugnara, C., Galactéros, F., & Lettre, G. (2017) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2017.05.005 · Cited by 23
Investigational selectin-targeted therapy of sickle cell disease
Okpala, I. E. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.963552 · Cited by 22
Pulmonary Hypertension in Sickle Cell Disease
Gladwin, M. T. (2009) · CRC Press eBooks · doi:10.3109/9781420094763-19 · Cited by 22
Increased circulating PEDF and low sICAM-1 are associated with sickle cell retinopathy
da Cruz, P. R. S., Lira, R. P. C., Filho, S., de Souza, B. B., Mitsuushi, F. N., Menaa, F., Fertrin, K. Y., de Vasconcellos, J. P. C., Conran, N., Costa, F. F., et al. (2014) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2014.08.003 · Cited by 21
Self-citationNot simply misshapen red cells: multimolecular and cellular events in sickle vaso-occlusion
Vercellotti, G. M., & Belcher, J. D. (2014) · Journal of Clinical Investigation · doi:10.1172/jci75238 · Cited by 21
Self-citationMiguel, L. I., Almeida, C. B., Traina, F., Canalli, A. A., Dominical, V. M., Saad, S. T. O., Costa, F. F., & Conran, N. (2011) · Inflammation Research · doi:10.1007/s00011-011-0315-8 · Cited by 21
Self-citationShi, P. A., Choi, E., Chintagari, N. R., Nguyen, J., Guo, X., Yazdanbakhsh, K., Mohandas, N., Alayash, A. I., Manci, E. A., Belcher, J. D., et al. (2016) · British Journal of Haematology · doi:10.1111/bjh.14280 · Cited by 21
Self-citationItokua, K. E., Makulo, J. R., Lepira, F. B., Aloni, M. N., Ekulu, P. M., Sumaili, E. K., Bukabau, J. B., Mokoli, V. M., Longo, A. L., Kajingulu, F., et al. (2016) · BMC Nephrology · doi:10.1186/s12882-016-0398-0 · Cited by 21
Kanavaki, I., Makrythanasis, P., Lazaropoulou, C., Kattamis, A., Tzanetea, R., Kalotychou, V., Rombos, I., & Papassotiriou, I. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2011.02551.x · Cited by 20
Elshazly, S. A., Heiba, N. M., & Abdelmageed, W. M. (2013) · Hematology · doi:10.1179/1607845413y.0000000092 · Cited by 20
Protective Role of Hemopexin on Heme-Dependent Lung Oxidative Stress
BARNARD, M. L., Müller‐Eberhard, U., & Turrens, J. F. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1384 · Cited by 20
Admission and length of stay due to painful vasoocclusive crisis in children
Rogovik, A. L., Li, Y., Kirby-Allen, M. A., Friedman, J., & Goldman, R. D. (2009) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2008.06.022 · Cited by 20
Kaul, D. K., Kollander, R., Mahaseth, H., Liu, X. D., Solovey, A. N., Belcher, J. D., Kelm, R. J., Vercellotti, G. M., & Hebbel, R. P. (2006) · Microcirculation · doi:10.1080/10739680600778456 · Cited by 19
Self-citationLactadherin mediates sickle cell adhesion to vascular endothelial cells in flowing blood
Guchhait, P., Dasgupta, S. K., Le, A., Yellapragada, S. V., López, J. A., & Thiagarajan, P. (2007) · Haematologica · doi:10.3324/haematol.11379 · Cited by 18
Pullarkat, V. A., Meng, Z., Tahara, S. M., Johnson, C. S., & Kalra, V. K. (2014) · Hemoglobin · doi:10.3109/03630269.2014.898651 · Cited by 17
Cerebrovascular complications in children with sickle cell disease
de Montalembert, M., & Wang, W. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-59565-2.00064-2 · Cited by 16
Marçal, L. E., Dias‐da‐Motta, P. M., Rehder, J., Mamoni, R. L., Blotta, M. H. S. L., Whitney, C., Newburger, P. E., Costa, F. F., Saad, S. T. O., & Condino‐Neto, A. (2007) · American Journal of Hematology · doi:10.1002/ajh.20991 · Cited by 16
A novel hemoglobin-binding peptide reduces cell-free hemoglobin in murine hemolytic anemia
Hanson, M. S., Xu, H., Flewelen, T. C., Holzhauer, S., Retherford, D. M., Jones, D. W., Frei, A. C., Pritchard, K. A., Hillery, C. A., Hogg, N., et al. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00500.2012 · Cited by 16
Owusu-Ansah, A. T., Choi, S. H., Petrošiūtė, A., Letterio, J. J., & Huang, A. Y.-C. (2014) · Frontiers of Medicine · doi:10.1007/s11684-015-0375-1 · Cited by 16
Gene therapy for hemoglobin disorders - a mini-review
Malik, P. (2016) · Journal of Rare Diseases Research & Treatment · doi:10.29245/2572-9411/2016/2.1028 · Cited by 16
Hensold, J. O., Barth, D., & Stratton, C. A. (1996) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199607)168:1<71::aid-jcp9>3.0.co;2-5 · Cited by 15
Prospects for early investigational therapies for sickle cell disease
Conran, N. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.1012292 · Cited by 15
Self-citationGarcía‐Morín, M., López-Sangüos, C., Vázquez, P., Alvárez, T., Marañón, R., Aragonés, J. H., & Cela, E. (2016) · Hemoglobin · doi:10.1080/03630269.2016.1275677 · Cited by 15
Elevated Circulating Stromal-Derived Factor-1 Levels in Sickle Cell Disease
Landburg, P. P., Nur, E., Maria, N. I., Brandjes, D. P. M., Biemond, B. J., Schnog, J. B., & Duits, A. J. (2009) · Acta Haematologica · doi:10.1159/000243727 · Cited by 14
IL1A rs1800587 Associates with Chronic Noncrisis Pain in Sickle Cell Disease
Hu, X., Jhun, E. H., Yao, Y., He, Y. Z., Molokie, R. E., Wilkie, D. J., & Wang, Z. J. (2016) · Pharmacogenomics · doi:10.2217/pgs-2016-0085 · Cited by 14
Driss, A., Wilson, N. O., Mason, K. P., Hyacinth, H. I., Hibbert, J. M., Serjeant, G. R., & Stiles, J. K. (2012) · Disease Markers · doi:10.1155/2012/479275 · Cited by 14
Rehani, T., Mathson, K., Belcher, J. D., Vercellotti, G. M., & Slungaard, A. (2013) · Blood · doi:10.1182/blood.v122.21.2215.2215 · Cited by 12
Self-citationConnes, P., Harmon, K. G., & Bergeron, M. F. (2012) · British Journal of Sports Medicine · doi:10.1136/bjsports-2012-091223 · Cited by 12
Clinical Manifestations and Treatment of Adult Sickle Cell Disease
Costa, F. F., & Fertrin, K. Y. (2016) · Springer eBooks · doi:10.1007/978-3-319-06713-1_12 · Cited by 12
Hemopexin decreases hemin accumulation and catabolism by neural cells
Chen‐Roetling, J., Liu, W., & Regan, R. F. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.01.024 · Cited by 11
Genetic Factors Modifying Sickle Cell Disease Severity
Gardner, K., & Thein, S. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-06713-1_15 · Cited by 11
A Novel, Highly Potent and Selective PDE9 Inhibitor for the Treatment of Sickle Cell Disease
McArthur, J. G., Maciel, T. T., Chen, C., et al. (2016) · Blood · doi:10.1182/blood.v128.22.268.268 · Cited by 11
Exogenous nitric oxide inhibits shedding of ADAM17 substrates.
Bzowska, M., Stalińska, K., Mężyk-Kopeć, R., Wawro, K., Duda, K., Das, S., & Bereta, J. (2009) · Acta Biochimica Polonica · doi:10.18388/abp.2009_2465 · Cited by 10
Nitric oxide inhibits the production of soluble endothelin converting enzyme-1
Kuruppu, S., Rajapakse, N. W., Dunstan, R. A., & Smith, A. I. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2141-0 · Cited by 10
Sess, D., Carbonneau, M. A., Thomas, M., Dumon, M. F., Peuchant, E., Perromat, A., Bras, M. L., & Clerc, M. (1992) · PubMed · Cited by 9
Inflammation and Sickle Cell Anemia
Almeida, C. B., Kato, G. J., & Conran, N. (2016) · Springer eBooks · doi:10.1007/978-3-319-06713-1_8 · Cited by 9
Self-citation
Metadata
- Authors
- Conran, N., & Belcher, J. D.
- Venue
- Clinical Hemorheology and Microcirculation
- Publisher
- SAGE Publications
- Published
- 2018-03-28
- Volume
- 68
- Issue
- 2-3
- Pages
- 263-299
- ISSN
- 1386-0291 (ISSN-L)
- 1875-8622
- OpenAlex
- W2794850401
- Cited by
- 294
- References
- 405
- FWCI
- 10.92
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.